美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,375.27

+19.551.44%

涨家数：17

跌家数：2

平家数：1

市盈率：- -

高：1,386.07

开：1,359.33

低：1,359.33

收：1,355.71

数据加载中...

BUZZ-Insulet 任命新任首席执行官，预示利润前景改善，公司股价上涨

Aethlon Medical, Inc.盘中异动早盘大幅上涨8.03%

Ibio, Inc.盘中异动急速拉升5.20%报0.967美元

Co-Diagnostics, Inc.盘中异动早盘股价大涨5.03%

诺瓦瓦克斯医药盘中异动快速拉升5.10%报7.01美元

诺纳生物合作伙伴辉瑞在2025 AACR年会上公布基于TOP1i靶向人间皮素ADC疗法的临床前数据

阿斯利康宣布最新架构和人事变动

阿斯利康中国架构大调整，高管变动引关注

生物科技馆

K药皮下剂型陷专利纠纷，罗氏再砍3条管线，阿斯利康联手3家本土药企

医药经济报

辉瑞4月25日成交额为8.20亿美元

莫德纳4月25日成交额为2.11亿美元

吉利德科学4月25日成交额为14.63亿美元

阿斯利康4月25日成交额为4.62亿美元

美股抗疫概念股多数下跌，BioNTech跌超15%

每日经济新闻

勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份

勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份

BUZZ-Novavax 因报告 FDA 要求对 COVID 疫苗进行新试验而下跌

据《华尔街日报》报导，美国 FDA 要求 Novavax 完成 COVID-19 延迟注射的新临床试验

据《华尔街日报》报导，FDA要求诺瓦克斯公司完成COVID-19延迟注射的新临床试验

诺瓦瓦克斯医药盘中异动股价大跌5.73%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1375.2667,"timestamp":1746215999999,"preClose":1355.7122,"halted":0,"volume":90281388,"delay":0,"changeRate":0.014424,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":19.554565,"latestTime":"05-02 16:00:00 EDT","open":1359.3263,"high":1386.07,"low":1359.3263,"amount":4683518595.783152,"amplitude":0.019727,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.677286,"peRate":21.976197,"turnoverRate":0.005819,"increases":17,"decrements":2,"flats":1,"marketCap":1136531230970,"floatMarketCap":1116501984572.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1386.07,"amplitude":0.019727,"preClose":1355.7122,"low":1359.3263,"pbRate":"3.677286","latestPrice":1375.2667,"volume":90281388,"delay":0,"open":1359.3263,"prevYearClose":1274.8187,"prevWeekClose":1341.1263,"prevMonthClose":1374.5028,"prevQuarterClose":1427.887,"fiveDayClose":1341.1263,"twentyDayClose":1401.546,"sixtyDayClose":1373.9138,"secType":"PLATE","market":"US","turnoverRate":0.005819,"peRate":21.976197,"marketCap":1136531230970,"floatMarketCap":1116501984572.5,"timestamp":1746215999999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":17,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530233536","title":"BUZZ-Insulet 任命新任首席执行官，预示利润前景改善，公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2530233536","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530233536?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 23:00","pubTimestamp":1745852405,"startTime":"0","endTime":"0","summary":"4月28日 - ** 医疗设备制造商 Insulet 宣布更换首席执行官，并对 2025 年的利润前景持乐观态度，该公司PODD.O股价周一上涨 1%，至 263.34 美元。** 公司定于 5 月 8 日收盘后发布第一季度财报。鉴于首席执行官的交接，该公司推迟了之前计划的 6 月 5 日投资者日活动，并打算重新安排。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4S3R61GO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550221.USD","LU0912757837.SGD","IE00B42XCP33.USD","IE00B3PB1722.GBP","LU1935042991.SGD","BK4585","LU0882574055.USD","LU0345769631.USD","BK4559","IE00B1BXHZ80.USD","LU1196500208.SGD","BK4568","BK4504","LU1430594728.SGD","BK4082","IE00BLSP4452.SGD","IE00B4R5TH58.HKD","LU1267930813.SGD","IE00BJT1NW94.SGD","LU0234570918.USD","LU1023059063.AUD","LU1244550494.USD","LU1718418525.SGD","JNJ","LU1162221912.USD","LU1066053197.SGD","LU0889566641.SGD","IE0002141913.USD","IE00BVYPNW00.USD","IE00B19Z3B42.SGD","LU2505996509.AUD","LU2592432038.USD","IE00B2B36J28.USD","LU1585245621.USD","LU0289739699.SGD","LU1929549753.HKD","IE00B19Z3581.USD","BK4551","LU2129689605.HKD","IE00BFTCPJ56.SGD","IE00BGHQF631.EUR","IE00BN8TJ469.HKD","BK4592","LU0345770993.USD","LU1221951129.SGD","LU0098860793.USD","LU0345769128.USD","PODD","LU1084165304.USD","BK4566"],"gpt_icon":0},{"id":"2530368062","title":"Aethlon Medical, Inc.盘中异动 早盘大幅上涨8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530368062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530368062?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 22:51","pubTimestamp":1745851884,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日22时51分，Aethlon Medical, Inc.股票出现异动，股价快速上涨8.03%。截至发稿，该股报0.412美元/股，成交量1.5359万股，换手率0.10%，振幅7.53%。Aethlon Medical, Inc.股票所在的医疗器械行业中，整体涨幅为0.55%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、Autonomix Medical, Inc.、Cvrx, Inc.涨幅较大，Tivic Health Systems, Inc.、Bluejay Diagnostics, Inc.、Reshape Lifesciences, Inc.较为活跃，换手率分别为31.88%、17.60%、10.24%，振幅较大的相关个股有Ss Innovations International Inc.、Cvrx, Inc.、Biosig Technologies, Inc.，振幅分别为28.11%、15.75%、15.22%。Aethlon Medical, Inc.公司简介：Aethlon Medical Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428225125a46aa46a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428225125a46aa46a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4583","BK4082","AEMD"],"gpt_icon":0},{"id":"2530379281","title":"Ibio, Inc.盘中异动 急速拉升5.20%报0.967美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530379281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530379281?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 21:38","pubTimestamp":1745847528,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时38分，Ibio, Inc.股票出现异动，股价大幅上涨5.20%。截至发稿，该股报0.967美元/股，成交量5.4601万股，换手率0.54%，振幅2.48%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213848a46a8ff0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213848a46a8ff0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBIO","BK4568","BK4139"],"gpt_icon":0},{"id":"2530286854","title":"Co-Diagnostics, Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530286854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530286854?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 21:36","pubTimestamp":1745847361,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时36分，Co-Diagnostics, Inc.股票出现异动，股价大幅上涨5.03%。Co-Diagnostics, Inc.股票所在的医疗器械行业中，整体涨幅为0.16%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、Ss Innovations International Inc.、Autonomix Medical, Inc.涨幅较大，Tivic Health Systems, Inc.、Bluejay Diagnostics, Inc.、Reshape Lifesciences, Inc.较为活跃，换手率分别为23.24%、7.31%、6.28%，振幅较大的相关个股有Ss Innovations International Inc.、Bluejay Diagnostics, Inc.、Heartsciences Inc.，振幅分别为15.86%、10.18%、9.97%。Co-Diagnostics, Inc.公司简介：Co-Diagnostics Inc是一家分子诊断公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213601a6cbc0ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213601a6cbc0ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CODX","BK4568","BK4082"],"gpt_icon":0},{"id":"2530835286","title":"诺瓦瓦克斯医药盘中异动 快速拉升5.10%报7.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530835286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530835286?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 21:31","pubTimestamp":1745847078,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时31分，诺瓦瓦克斯医药股票出现异动，股价大幅拉升5.10%。截至发稿，该股报7.01美元/股，成交量27.4853万股，换手率0.17%，振幅0.30%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1124.08%、302.99%、60.94%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Vaxart, Inc. - Common Stock、Fibrobiologics, Inc.，振幅分别为7.64%、5.71%、5.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213118a46a8dc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213118a46a8dc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","BK4547","BK4588","NVAX","BK4585"],"gpt_icon":1},{"id":"2530497866","title":"诺纳生物合作伙伴辉瑞在2025 AACR年会上公布基于TOP1i靶向人间皮素ADC疗法的临床前数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2530497866","media":"医药魔方","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530497866?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 08:31","pubTimestamp":1745800285,"startTime":"0","endTime":"0","summary":"诺纳生物，一家致力于前沿技术创新，并为合作伙伴提供涵盖靶点验证和新一代生物大分子药物从发现至临床前研发等Idea to IND完整服务的国际化创新生物技术公司，今日宣布其合作伙伴辉瑞在2025年美国癌症研究协会年会上公布了同类首创基于拓扑异构酶1抑制剂的靶向人间皮素抗体偶联药物PF-08052666的临床前数据。2023年12月14日，辉瑞获得了其全球临床开发和商业化权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428102605a469cf3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428102605a469cf3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066051498.USD","LU1057294990.SGD","IE00BBT3K403.USD","LU0170899867.USD","LU0234572021.USD","LU0306806265.USD","SG9999003800.SGD","BK4581","BK4080","LU0225771236.USD","LU1894683348.USD","IE00B19Z3581.USD","SG9999002224.SGD","LU0058720904.USD","BK4231","IE0002270589.USD","IE000M9KFDE8.USD","LU0321505868.SGD","LU0122379950.USD","LU0321505439.SGD","SG9999001176.USD","LU1883839398.USD","BK4568","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4550","ADC","LU0289739699.SGD","LU0868494617.USD","LU0456855351.SGD","LU0306807586.USD","LU0985481810.HKD","SG9999002232.USD","BK4585","IE00BLSP4239.USD","SG9999013999.USD","BK4592","PFE","SG9999011175.SGD","SGXZ57979304.SGD","BK4534","LU1066053197.SGD","LU1894683264.USD","BK4007","BK4599","IE00BLSP4452.SGD","BK4533","LU0225284248.USD","BK4588","LU1023059063.AUD"],"gpt_icon":1},{"id":"2530141329","title":"阿斯利康宣布最新架构和人事变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2530141329","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530141329?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 12:23","pubTimestamp":1745641380,"startTime":"0","endTime":"0","summary":"阿斯利康中国宣布组织架构调整和人事变动，聚焦呼吸与自体免疫、疫苗及免疫疗法两大领域。新设两大事业部，并有多项人事任命和离职。此举与公司产品管线进展密切相关，计划至2030年在中国引入至少20款创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042615321894e37d19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042615321894e37d19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1829250122.USD","LU2462157665.USD","BK4568","LU2417539215.USD","LU2456880835.USD","LU0889565916.HKD","LU0320765992.SGD","BK4585","LU0109394709.USD","BK4588","BK4007","AZN","LU2236285917.USD"],"gpt_icon":0},{"id":"2530146694","title":"阿斯利康中国架构大调整，高管变动引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2530146694","media":"生物科技馆","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530146694?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 11:46","pubTimestamp":1745639184,"startTime":"0","endTime":"0","summary":"今日，阿斯利康中国掀起了一场备受瞩目的组织架构变革，此次调整堪称 2025 年规模最大的一次。目前已知，现任阿斯利康中国助理副总裁童沁杰将继续掌舵慢阻肺病业务部，不过 R&I 事业部负责人的最终人选尚未确定。三位高管离任消息公布与此同时，阿斯利康中国今日还宣布了三位高管离任的消息。去年 10 月，阿斯利康中国对 BBU 进行架构调整，多个业务部门进行合并，刘谦被任命为阿斯利康中国呼吸消化事业部总经理。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426150645a467cffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426150645a467cffa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4568","BK4585","LU1829250122.USD","LU2462157665.USD","LU0109394709.USD","LU2417539215.USD","LU2236285917.USD","AZN","LU0889565916.HKD","LU2456880835.USD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2530114058","title":"K药皮下剂型陷专利纠纷，罗氏再砍3条管线，阿斯利康联手3家本土药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2530114058","media":"医药经济报","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530114058?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 11:02","pubTimestamp":1745636535,"startTime":"0","endTime":"0","summary":"K药皮下剂型被诉专利侵权4月24日，美国生物技术公司Halozyme在新泽西州的美国地方法院对默沙东提起专利侵权诉讼。据悉，Halozyme的MDASE皮下递送技术利用人透明质酸酶实现药物的快速、大容量皮下注射。为此，Halozyme正在寻求损害赔偿和禁令救济，以阻止默沙东的侵权行为。在肺癌领域，阿斯利康积极推动研究创新疗法，已与6家本土药企达成合作，推进8项联合治疗研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426112537a467a720&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426112537a467a720&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","LU2361044949.HKD","IE00B1BXHZ80.USD","LU0265550946.USD","LU0965509101.SGD","LU1989771016.USD","BK4568","LU2461242641.AUD","LU1699723380.USD","LU2324357040.USD","IE00BLSP4452.SGD","LU0861579265.USD","LU2361044865.SGD","BK4550","LU1037948897.HKD","LU2361045086.USD","LU2456880835.USD","MRK","IE00B4R5TH58.HKD","LU1069347547.HKD","LU1934455194.USD","LU2023250504.SGD","LU1934455863.HKD","IE000M9KFDE8.USD","SG9999001440.SGD","LU1116320901.HKD","BK4533","LU1162221912.USD","SG9999015341.SGD","AZN","SG9999013999.USD","SG9999015358.SGD","IE00BN8TJ469.HKD","LU0320765489.SGD","LU1066053197.SGD","LU1430594728.SGD","IE0002141913.USD","LU0266013472.USD","LU2468319806.SGD","LU0265550359.USD","LU2023250843.SGD","SGXZ57979304.SGD","LU0320765992.SGD","LU1989772923.USD","IE00BJT1NW94.SGD","LU0203345920.USD","IE00BJJMRZ35.SGD","LU1941712264.USD","LU1035773651.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"2530772119","title":"辉瑞4月25日成交额为8.20亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530772119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530772119?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 10:18","pubTimestamp":1745633897,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，辉瑞成交额为8.20亿美元，成交额较昨日增加3.34%，当日成交量为3584.77万股。辉瑞于2025年4月25日涨0.61%，报22.92美元，该股过去5个交易日涨3.52%，年初至今跌12.18%，过去60日跌13.9%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-25|8.20亿|3.34%|3584.77万|#|2025-04-24|7.94亿|-30.67%|3500.96万|#|2025-04-23|11.45亿|41.51%|5078.10万|#|2025-04-22|8.09亿|14.76%|3605.26万|#|2025-04-21|7.05亿|-41.56%|3202.10万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426101825a46793a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426101825a46793a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0058720904.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2530197281","title":"莫德纳4月25日成交额为2.11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530197281","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530197281?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 10:02","pubTimestamp":1745632934,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，莫德纳成交额为2.11亿美元，成交额较昨日增加62.78%，当日成交量为771.91万股。莫德纳于2025年4月25日跌0.62%，报27.22美元，该股过去5个交易日涨10.11%，年初至今跌34.54%，过去60日跌33.15%。截至 2024年9月，莫德纳拥有处于临床试验中的40个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100215a6c8d01f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100215a6c8d01f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4501","MRNA","BK4548","BK4139","BK4533","BK4532","BK4585","BK4588","BK4568","BK4551"],"gpt_icon":0},{"id":"2530119082","title":"吉利德科学4月25日成交额为14.63亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530119082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530119082?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 09:34","pubTimestamp":1745631298,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，吉利德科学成交额为14.63亿美元，成交额较昨日增加35.59%，当日成交量为1420.82万股。吉利德科学于2025年4月25日跌2.81%，报103.17美元，该股过去5个交易日跌1.31%，年初至今涨12.48%，过去60日涨8.69%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426093502a6c8c7b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426093502a6c8c7b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2089984988.USD","IE00B19Z3B42.SGD","BK4532","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","BK4583","LU1839511570.USD","IE00B3T34201.USD","LU1585245621.USD","GILD","LU0058720904.USD","LU2468319806.SGD","BK4588","BK4566","LU1066053197.SGD","LU0109394709.USD","LU0320765992.SGD","LU0234570918.USD","BK4550","BK4568","IE00BZ1G4Q59.USD","LU2087621335.USD","IE00BKVL7J92.USD","BK4139","BK4585","LU0889565916.HKD","LU1066051498.USD","LU0289739699.SGD","IE0002270589.USD","LU1571399168.USD","LU1430594728.SGD","BK4578","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2530607113","title":"阿斯利康4月25日成交额为4.62亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530607113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530607113?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 09:16","pubTimestamp":1745630209,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，阿斯利康成交额为4.62亿美元，成交额较昨日增加94.02%，当日成交量为666.27万股。阿斯利康于2025年4月25日涨0.03%，报69.57美元，该股过去5个交易日涨2.93%，年初至今涨7.91%，过去60日涨0.53%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-25|4.62亿|94.02%|666.27万|#|2025-04-24|2.38亿|-38.92%|343.21万|#|2025-04-23|3.90亿|-1.09%|567.40万|#|2025-04-22|3.94亿|128.16%|580.70万|#|2025-04-21|1.73亿|-32.74%|257.30万|1999 年，瑞典阿斯特拉公司与英国捷利康集团合并，成立了阿斯利康公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426091702a467845e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426091702a467845e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4007","LU2462157665.USD","BK4588","LU2236285917.USD","LU0109394709.USD","LU1829250122.USD","LU2417539215.USD","LU0889565916.HKD","LU2456880835.USD","BK4568","AZN","BK4585"],"gpt_icon":0},{"id":"2530868192","title":"美股抗疫概念股多数下跌，BioNTech跌超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530868192","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530868192?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 06:55","pubTimestamp":1745621711,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月26日，美股抗疫概念股多数下跌，Moderna跌0.62%，吉利德科学跌超2%，诺瓦瓦克斯医药跌逾5%，BioNTech跌超15%，阿斯利康涨0.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504263389420366.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504263389420366.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BKVL7J92.USD","IE00B19Z3581.USD","LU1066053197.SGD","LU1066051498.USD","BK4547","LU2468319806.SGD","IE00BSNM7G36.USD","BK4139","GILD","BK4550","IE00B19Z3B42.SGD","LU1585245621.USD","LU1430594728.SGD","IE00B7SZLL34.SGD","BK4585","LU0320765992.SGD","LU0109394709.USD","LU0289739699.SGD","LU1839511570.USD","BK4532","BK4583","BK4588","LU1571399168.USD","LU0234570918.USD","BK4566","LU2087621335.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","BK4578","LU0058720904.USD","IE0002270589.USD","LU0889565916.HKD","IE00B3T34201.USD","BK4568"],"gpt_icon":0},{"id":"2530196258","title":"勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2530196258","media":"路透中文","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530196258?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 06:09","pubTimestamp":1745618944,"startTime":"0","endTime":"0","summary":"勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份Svea Herbst-Bayliss路透纽约4月25日 - 熟悉内情的消息人士周五透露，亿万富翁投资者丹尼尔-勒布的对冲基金Third Point正在增持KenvueKVUE.N的股份，因为一些投资者正在推动这家消费保健品公司进行战略调整。目前还不能确定 Third Point 的投资规模有多大，也不能确定该对冲基金是否与 Kenvue 董事会或管理层进行了接触。Third Point 的一位代表拒绝发表评论。英国《金融时报》周五首次报导了 Third Point 持有 Kenvue 股份的消息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4T3R3245:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","LU0795875169.SGD","LU2430703095.HKD","BBWI","IE00BLSP4452.SGD","LU0320765489.SGD","SG9999001440.SGD","BK4568","LU1162221912.USD","SG9999015952.SGD","BK4559","LU1732799900.SGD","LU1074936037.SGD","LU1244550221.USD","BK4524","IE00B19Z3581.USD","IE00BJT1NW94.SGD","LU1196500208.SGD","LU0058720904.USD","LU1674673428.USD","AAP","BK4554","LU1244550494.USD","IE00BVYPNV92.GBP","LU1718418525.SGD","LU1032466523.USD","LU0203347892.USD","LU1261432733.SGD","KVUE","LU0466842654.USD","LU1032955483.USD","LU1221951129.SGD","IE00B7SZLL34.SGD","LU2602419157.SGD","LU0122379950.USD","IE0002270589.USD","BK4507","IE00BFTCPJ56.SGD","LU0070302665.USD","LU0114720955.EUR","LU0345770993.USD","LU1585245621.USD","BK4183","LU0310800379.SGD","LU2347655156.SGD","IE00B2B36J28.USD","LU2430703251.USD","LU2129689514.USD","LU2505996509.AUD"],"gpt_icon":1},{"id":"2530196237","title":"勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2530196237","media":"路透中文","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530196237?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 06:09","pubTimestamp":1745618944,"startTime":"0","endTime":"0","summary":"勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份Svea Herbst-Bayliss路透纽约4月25日 - 熟悉内情的消息人士周五透露，亿万富翁投资者丹尼尔-勒布的对冲基金Third Point正在增持KenvueKVUE.N的股份，因为一些投资者正在推动这家消费保健品公司进行战略调整。目前还不能确定 Third Point 的投资规模有多大，也不能确定该对冲基金是否与 Kenvue 董事会或管理层进行了接触。Third Point 的一位代表拒绝发表评论。英国《金融时报》周五首次报道了 Third Point 持有 Kenvue 股份的消息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4S3R3245:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU0058720904.USD","LU0466842654.USD","LU1032955483.USD","LU0122379950.USD","LU0795875169.SGD","LU1732799900.SGD","LU2430703251.USD","LU1261432733.SGD","LU1032466523.USD","LU0203347892.USD","LU0320765489.SGD","SG9999001440.SGD","LU1074936037.SGD","LU0114720955.EUR","LU2430703095.HKD","BK4559","IE00BLSP4452.SGD","LU1244550494.USD","IE00B2B36J28.USD","BBWI","BK4568","LU0310800379.SGD","IE00BFTCPJ56.SGD","LU1221951129.SGD","LU1718418525.SGD","LU1162221912.USD","IE0002270589.USD","LU2602419157.SGD","LU2505996509.AUD","KVUE","IE00B19Z3581.USD","LU1585245621.USD","LU1196500208.SGD","IE00BJT1NW94.SGD","IE00B7SZLL34.SGD","IE00BVYPNV92.GBP","SG9999015952.SGD","LU2347655156.SGD","BK4524","BK4554","BK4183","LU1244550221.USD","AAP","LU0070302665.USD","LU0345770993.USD","JNJ","LU2129689514.USD","BK4507"],"gpt_icon":1},{"id":"2530629031","title":"BUZZ-Novavax 因报告 FDA 要求对 COVID 疫苗进行新试验而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2530629031","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530629031?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 03:46","pubTimestamp":1745610380,"startTime":"0","endTime":"0","summary":"4月25日 - ** 疫苗生产商 Novavax NVAX.O 的股价在下午的交易中下跌 6.6% 至 6.61 美元** 华尔街日报》援引熟悉内情的人士的话报导称，尽管此前COVID-19疫苗的有效率达到了90%，但美国食品和药物管理局仍要求Novavax为其COVID-19疫苗再进行一次临床试验。** 周三，NOVAX称，如果COVID-19疫苗获得全面批准，美国食品和药物管理局要求该公司提供更多数据， 。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7884860a095da688d55e8f59fb0acbc9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4T3R31V1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","BK4547","BK4585","NVAX","BK4588"],"gpt_icon":1},{"id":"2530623691","title":"据《华尔街日报》报导，美国 FDA 要求 Novavax 完成 COVID-19 延迟注射的新临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2530623691","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530623691?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 03:40","pubTimestamp":1745610029,"startTime":"0","endTime":"0","summary":"更新版 4-据《华尔街日报》报导，美国 FDA 要求 Novavax 完成 COVID-19 延迟注射的新临床试验在第 4 和第 5 段中添加了 Novavax 公司的评论意见据《华尔街日报》报导，FDA 要求对 COVID-19 注射剂进行新的试验Novavax 股票收盘下跌近 6. 路透4月25日 - 据《华尔街日报》周五援引知情人士的话报导，在此前推迟批准COVID-19疫苗后，联邦监管机构要求Novavax NVAX.O完成一项额外的临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7884860a095da688d55e8f59fb0acbc9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4T3R31UO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","BK4547","NVAX","BK4585","BK4588"],"gpt_icon":1},{"id":"2530644271","title":"据《华尔街日报》报导，FDA要求诺瓦克斯公司完成COVID-19延迟注射的新临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2530644271","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530644271?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 03:30","pubTimestamp":1745609453,"startTime":"0","endTime":"0","summary":"据《华尔街日报》报导，FDA要求诺瓦克斯公司完成COVID-19延迟注射的新临床试验路透4月25日 - 据《华尔街日报》周五援引熟悉内情的人士的话报导，在此前推迟批准Covid-19疫苗后，联邦监管机构要求Novavax NVAX.O完成额外的临床试验。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7884860a095da688d55e8f59fb0acbc9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4T3R31U8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4585","BK4568","BK4588","BK4139","NVAX"],"gpt_icon":0},{"id":"2530164896","title":"诺瓦瓦克斯医药盘中异动 股价大跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530164896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530164896?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 03:20","pubTimestamp":1745608845,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日03时20分，诺瓦瓦克斯医药股票出现波动，股价大幅下挫5.73%。截至发稿，该股报6.67美元/股，成交量431.707万股，换手率2.68%，振幅6.42%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，29%的券商给予持有建议，14%的券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体跌幅为0.11%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家从事疫苗开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426032045a6c86d26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426032045a6c86d26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","NVAX","BK4568","BK4547","BK4139","BK4588"],"gpt_icon":1}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":178,"code":"91000000","status":"200"}]}}